TraceLink grows its market position in DACH region by over 200%

TraceLink, the Track and Trace Network for connecting the life sciences supply chain, has revealed growth in its market position within the DACH region (Germany, Austria and Switzerland) of 215% for 2017.

This 138% growth in revenues has been achieved by expanding the customer base of the region, which is now at 40. Additionally, to meet the demand by this increased customer base the company has grown its European team by 169% and is currently employing 22 native German-speaking team members.

“We have customers and partners located all over the world and could not afford to lose time and resources by establishing individual point-to-point connections,” said Ortwin Kottwitz, CEO of Germany-based biotech and TraceLink customer, biosyn. “After a thorough evaluation of solution providers, it was clear that TraceLink’s network approach would deliver the scalability we needed while providing a simple and fast connection into the EU Hub.”

“As a contract manufacturer, we need to be able to connect to multiple customers, managing and sharing data securely and efficiently,” explained Michael Unbehaun, manager engineering projects at R-Pharm Germany, a TraceLink partner. “By accessing the TraceLink Life Sciences Cloud we can facilitate EU FMD compliance for our customers who supply markets in Europe. The simplicity of the solution, together with our proactive approach, has helped our customers achieve compliance ahead of the regulatory deadline.”

“Our partnership with TraceLink has allowed us to manage and exchange serialisation data more efficiently by eliminating outdated data transfer processes and simplifying the onboarding process for our customers,” added Boris Brunow of Switzerland-based contract packaging organisation (CPO) Allpack, a TraceLink customer. “We evaluated potential partners over a two-year period, eventually selecting TraceLink for its network approach, as well as its specialist focus in the pharma sector.”

“The EU FMD deadline is now less than a year away, requiring businesses to begin actively preparing for their serialisation and regulatory requirements now. Over 190 companies are already serialising with TraceLink and with more than 265,000 partners on our network, we are well positioned to serve the growing number of companies of all sizes in Germany, Austria and Switzerland,” said Shabbir Dahod, president and CEO, TraceLink. “On an organisational level, we now have more employees dedicated to serving the DACH region than some of our competitors have for total number of employees, giving TraceLink a distinct advantage in our ability to service the specific needs of pharmaceutical and contract manufacturers across the region.”

Supporting companies both in the DACH region and across Europe, TraceLink is hosting its annual event, FutureLink from 5–7 June in Munich. This conference will see commercial and operational executives gather to develop strategies to address the approaching compliance deadlines and to discuss the analogue-to-digital information-sharing transformation taking place in the pharmaceutical and healthcare industries.